You are here:

Home
NICE Guidance
Conditions and diseases
Cancer
Renal cancer

Axitinib for treating advanced renal cell carcinoma after failure of prior systemic treatment

Technology appraisal guidance
Reference number: TA333
Published: 25 February 2015

Guidance
Tools and resources
Information for the public
History

Renal cell carcinoma (advanced) - axitinib: appeal

For more information on the Technology Appraisal Appeal Process, go to the appeal hearings homepage.

Renal cell carcinoma (advanced) - axitinib: appeal decision
Renal cell carcinoma (advanced) - axitinib: appeal announcement
Renal cell carcinoma (advanced) - axitinib: notice of appeal

This page was last updated: 02 September 2013